lack of buying

As VHL approaches Phase II results, it's a little concerning to see the lack of buying.

A decent announcement recently, safety doesn't look an issue and results look to be on track for late July/August.

So, why the lack of investor interest? Do the believers already have their bets on? I'm hoping we get a decent result. A poor result would be a major setback as this is their most advanced program. Massive leverage, but good results is the main driver in my mind rather than the Transgene possibilities.

Crossing my fingers for a good phase II result. Looking for a 1 Log or greater reduction in viral load.